The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBILB.L Regulatory News (BILB)

  • There is currently no data for BILB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Banking Facilities

26 May 2020 08:06

RNS Number : 9140N
Bilby PLC
26 May 2020
 

26 May 2020

Bilby plc

("Bilby" or the "Company") 

New Banking Facilities

 

Bilby Plc (AIM: BILB), a leading gas heating, electrical and building services provider is pleased to announce that it has secured new banking facilities. The new facilities reflect the Company's much improved financial position and the continued support from its debt providers.

 

As previously announced, in the year to 31 March 2020, and as part of the strategic review, the business took significant steps to strengthen its balance sheet which, together with strong cash generation from operating activities, led to net debt dropping by 32% from the year ending 31 March 2019 position of £10.9 million to £7.4 million at 31 March 2020. The net debt position has improved further post year end to £5.7 million on 1 May 2020, comprising of overdraft of £1.8 million, term loan of £3.3 million and other borrowings of £0.6 million.

 

The Company received approval from its banking partner, HSBC, in November 2019 to make amendments to its financial covenants up to June 2020, which provided additional time and flexibility for the Group to enter into new debt facilities with rebased financial covenants.

 

The Board is pleased to have now reached an agreement on the new debt facilities. The new debt facilities total £9.8 million. The Group's previous debt facility was in the form of a £3.3 million term loan and a £6.5m overdraft facility (of which £1.8 million was utilised as of 1 May 2020). This debt facility has been restructured and now represents a £7.3 million term loan facility and a £2.5 million overdraft facility. The Group has prudently fully drawn down on this increased additional term loan facility to increase cash balances by £4.0 million. The facility expires in September 2022 and there will be £0.5 million quarterly repayments starting in August 2020.

 

In addition, Bilby has agreed with HSBC that the first covenant test for the Company will be to achieve a minimum EBITDA of £1.1 million for the year ending 31 March 2021, meeting the mandatory requirement for a covenant to be in place against the facilities. The covenants for the period beyond 31 March 2021 will be tested quarterly and they are (i) achievement of minimum levels of EBITDA; (ii) debt service cover; and (iii) interest cover.

 

The new facility and changes to the covenants provide maximum flexibility for the Group, which continues to benefit from long term contracts and, when conditions allow, will enable Bilby to capture revenues from deferred work as a result of COVID 19.

 

The Group continues to intend to announce its results for the year ending 31 March 2020 in July 2020 and is expected, subject to audit, to report revenues in the region of £65 million and an underlying EBITDA of approximately £4.6 million.

 

David Bullen, CEO of Bilby, commented:

"We appreciate the continued support of our long-term partner, HSBC with whom we retain a strong relationship. The restructuring of our facilities underpins the Group's business plan, and provides us with the confidence to both navigate the challenges that COVID 19 presents and ensure that the business is fully funded to achieve long term, sustainable growth."

 

 

 

 

 

 

Enquiries

 

Bilby plc

 

Sangita Shah, Chairman

David Bullen, Chief Executive Officer

 

+44 (0)20 7796 4133

(via Hudson Sandler)

 

 

Canaccord Genuity Limited (Nominated Adviser and Sole Broker)

+44 (0)20 7523 8000

Corporate Broking:

Bobbie Hilliam

Andrew Potts

Georgina McCooke

Sales:

Jonathan Barr

 

 

 

Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Charlie Jack

Bertie Berger

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUNRBRRSUVURR
Date   Source Headline
16th Jun 20214:46 pmRNSChange of name to Kinovo plc
24th May 20216:12 pmRNSDirector/PDMR Shareholding
12th May 20214:57 pmRNSDirector/PDMR Shareholding
6th May 202110:09 amRNSHolding(s) in Company
6th May 20217:00 amRNSYear-end trading update
15th Apr 20214:41 pmRNSSecond Price Monitoring Extn
15th Apr 20214:35 pmRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSDirector/PDMR Shareholding
23rd Mar 20214:16 pmRNSHolding(s) in Company
18th Mar 20212:01 pmRNSHolding(s) in Company
12th Mar 20214:41 pmRNSSecond Price Monitoring Extn
12th Mar 20214:36 pmRNSPrice Monitoring Extension
11th Mar 20219:37 amRNSHolding(s) in Company
11th Mar 20219:11 amRNSDirector/PDMR Shareholding and Share Plan
8th Feb 20214:49 pmRNSHolding(s) in Company
28th Jan 20213:58 pmRNSHolding(s) in Company
24th Dec 20207:00 amRNSJoint Share Ownership Plan
1st Dec 20207:00 amRNSHalf Year results
13th Nov 20207:00 amRNSTrading update and Board restructure
14th Oct 20204:40 pmRNSHolding(s) in Company
12th Oct 20208:15 amRNSHolding(s) in Company
5th Oct 202011:04 amRNSReplacement: Holding(s) in Company
30th Sep 202011:33 amRNSHolding(s) in Company
30th Sep 202011:28 amRNSHolding(s) in Company
16th Sep 20206:07 pmRNSDirector/PDMR Shareholding
14th Sep 202011:34 amRNSResult of AGM
11th Sep 202010:07 amRNSBoard change
14th Aug 202011:08 amRNSHolding(s) in Company
14th Aug 202010:35 amRNSAnnual Report and Notice of AGM
27th Jul 20201:27 pmRNSHolding(s) in Company
27th Jul 20207:00 amRNSFull Year Results
16th Jul 20207:00 amRNSNotice of Results
26th May 20208:06 amRNSNew Banking Facilities
7th May 20207:00 amRNSDirector/PDMR Shareholding
28th Apr 20203:44 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSYear-end and COVID-19 trading update
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
11th Mar 20203:41 pmRNSDirector/PDMR Shareholding
19th Dec 20197:00 amRNSInterim Results
3rd Dec 20194:48 pmRNSNotice of Results
25th Nov 20197:00 amRNSDirectorate Change
22nd Nov 20197:00 amRNSHolding(s) in Company
21st Nov 201912:07 pmRNSHolding(s) in Company
20th Nov 20195:40 pmRNSHolding(s) in Company
20th Nov 20194:40 pmRNSHolding(s) in Company
15th Nov 20198:02 amRNSResult of Fundraise
14th Nov 20194:52 pmRNSProposed Fundraise
28th Oct 20194:21 pmRNSResult of Annual General Meeting
30th Sep 201911:59 amRNSAnnual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.